Baxter International Inc. [NYSE: BAX] slipped around -0.65 points on Thursday, while shares priced at $42.63 at the close of the session, down -1.50%. The company report on April 1, 2024 at 7:15 AM that Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy.
Novum IQ Infusion Platform now offers large volume and syringe infusion smart pumps on an integrated system with shared innovative digital health solutions to help enhance patient safety and efficiency for clinicians.
Common user interface and connectivity across both pump modalities are designed to help reduce workflow burden and allow more time focused on patient care.
Compared to the average trading volume of 3.77M shares, BAX reached a trading volume of 3098831 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Baxter International Inc. [BAX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BAX shares is $44.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BAX stock is a recommendation set at 2.47. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Morgan Stanley have made an estimate for Baxter International Inc. shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on May 30, 2023. While these analysts kept the previous recommendation, UBS raised their target price to Neutral. The new note on the price target was released on March 29, 2023, representing the official price target for Baxter International Inc. stock. Previously, the target price had yet another raise to $55, while Morgan Stanley analysts kept a Equal-Weight rating on BAX stock.
The Average True Range (ATR) for Baxter International Inc. is set at 0.92, with the Price to Sales ratio for BAX stock in the period of the last 12 months amounting to 1.45. The Price to Book ratio for the last quarter was 2.58, with the Price to Cash per share for the same quarter was set at 6.30. Price to Free Cash Flow for BAX in the course of the last twelve months was 20.94 with Quick ratio for the last quarter at 1.04.
How has BAX stock performed recently?
Baxter International Inc. [BAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.14. With this latest performance, BAX shares gained by 0.52% in over the last four-week period, additionally plugging by 15.91% over the last 6 months – not to mention a rise of 6.63% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BAX stock in for the last two-week period is set at 54.00, with the RSI for the last a single of trading hit 52.25, and the three-weeks RSI is set at 55.17 for Baxter International Inc. [BAX]. The present Moving Average for the last 50 days of trading for this stock 41.28, while it was recorded at 43.02 for the last single week of trading, and 39.85 for the last 200 days.
Baxter International Inc. [BAX]: Deeper insight into the fundamentals
Baxter International Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.04 and a Current Ratio set at 1.48.
Earnings analysis for Baxter International Inc. [BAX]
With the latest financial reports released by the company, Baxter International Inc. posted 0.49/share EPS, while the average EPS was predicted by analysts to be reported at 0.49/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BAX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Baxter International Inc. go to 4.07%.
Insider trade positions for Baxter International Inc. [BAX]
The top three institutional holders of BAX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in BAX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in BAX stock with ownership which is approximately 5.8386%.
